Eli Lilly pays $30m signing fee to tap into Johannes Gutenberg University Mainz immunotherapy spin-out BioNTech.

Immuno-oncology company PsiOxus has secured $39m in a series C round featuring existing investors including GlaxoSmithKline and Lundbeck.

UK-based early-stage investor Mercia Fund Management names new investment director and head of technology transfer.

The company, which announced a corporate venturing unit earlier this month, will invest in three to four aerospace, defence or security technology companies a year, it has told GCV.

Corporate-backed fund Business Growth Fund has invested $15.7m in the remotely-operated vehicle maker, which plans to now expand in the Americas.

The engine and automotive technology company plans to step up its corporate venturing activity, Head of Corporate Venture Capital Kai Engelhardt revealed.